Information updates

Nominations for National Allergy Council

Full ASCIA members and Associate (Nurse) members are invited to submit Expressions of Interest (EOI) for the following voluntary ASCIA representative roles on the National Allergy Council Shared Care Model (SCM) project overarching working group:

  • Clinical immunology/allergy specialist working in paediatric public and/or private practice.
  • Clinical immunology/allergy specialist working in adult public and/or private allergy practice.
  • Allergy nurse working in paediatric public and/or adult public practice.

For your reference, a brief overview of the National Allergy Council SCM project is available here: pdfNational Allergy Council Shared Care Model Project Overview Nov 20221.42 MB

This project will address issues related to access to quality healthcare for Australians with allergy, particularly those living in regional, rural and remote areas. Therefore, experience with setting up multidisciplinary models of care for chronic health conditions, standards of care, and/or a regional, rural or remote perspective would be an advantage, but is not essential. 

ASCIA members interested in these roles should email an EOI (up to one A4 page) and a brief CV to This email address is being protected from spambots. You need JavaScript enabled to view it. by Thursday 9 February 2023. 

The National Allergy Council is a partnership between the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia, working with the National Allergy Centre of Excellence (NACE), in consultation with key stakeholder organisations. Dr Katie Frith (representing ASCIA) and Maria Said AM (representing A&AA) are the co-leads for this project. 

The purpose of the overarching National Allergy Council SCM project working group is to:

  • Support the project co-leads in providing strategic oversight and direction across all components of the SCM project.
  • Guide national stakeholder consultations.
  • Support smaller working groups tasked with delivering various components of the SCM project.
  • Establish or build on networks and partnerships, ensuring a linked and collaborative approach.

National Allergy Council SCM working groups will:

  • Commence in March 2023 and will initially meet  for 1–2 hours duration, approximately 6 times per year. Most meetings will occur via videoconference, however occasionally a face-to-face meeting may be necessary, in which case the National Allergy Council will fund travel costs. As these roles are voluntary, no remuneration will be provided. 
  • Implement deliverables according to the National Allergy Council Activity Work Plan, which is funded by the Australian Government Department of Health, over four years (2023 to 2026). This work should lead to significant changes in standards of care, education and training for allergy in Australia. 
  • Be listed on the National Allergy Council website and acknowledged at national meetings, conferences and publications.

In addition to the three ASCIA representative roles listed above, all ASCIA members will be given the opportunity to self-nominate for one of the sub-groups tasked with progressing specific components of the National Allergy Council SCM project. Initially, there will be two sub-groups:

  • Education, training, and scope of practice.
  • Standards of care for allergic diseases. 

To subscribe to communications about the National Allergy Council SCM project email This email address is being protected from spambots. You need JavaScript enabled to view it. with the subject SUBSCRIBE.

This news item was issued on 25 January 2023 by Jill Smith, CEO of the Australasian Society of Clinical Immunology and Allergy (ASCIA). ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand. 



Mod ASCIA Member
Donate to AIFA
go to NAC website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia